Cropin Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.60 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 620.50%
- Profit Growth -17.74%
- Ebitda -6.99%
- Net Worth 19.98%
- Total Assets 305.19%
About Cropin Biotech
Cropin Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2019 (Five years and 11 months 6 days old ). Its registered office is in Khandwa, Madhya Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Harshit Samediya and Manglesh Samediya serve as directors at the Company.
Company Details
- Location
Khandwa, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MP2019PTC048126
- Company No.
048126
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
What products or services does Cropin Biotech Private Limited offer?
Cropin Biotech Private Limited offers a wide range of products and services, including Seeds and Plant Saplings, Vegetable Seeds, Hybrid Seeds, Fruit Seeds.
Who are the key members and board of directors at Cropin Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harshit Samediya | Additional Director | 12-Dec-2024 | Current |
Manglesh Samediya  | Director | 20-Mar-2019 | Current |
Financial Performance of Cropin Biotech.
Cropin Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 620.5% increase. The company also saw a substantial fall in profitability, with a 17.74% decrease in profit. The company's net worth Soared by an impressive increase of 19.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cropin Biotech?
Unlock access to Cropin Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cropin Biotech?
Unlock and access historical data on people associated with Cropin Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cropin Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cropin Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
